ViiV Healthcare has reported several successful HIV trials at CROI 2026, including its investigational candidates lotivibart, VH184 and VH499.

Automation transforms vaccination into a traceable, well‑controlled operation that supports performance metrics.

ViiV Healthcare presents data for two investigational HIV treatment therapies with potential for twice-yearly dosing: London Saturday, February 28, 2026, 13:00 Hrs [IST] ViiV Heal ...

For use outside the EU, the regulator backed a single-dose oral approach that treats all stages and could spare patients ...

A small stable of doctors gave V.I.P. medical services to the sex offender and the women around him. Some doctors bent or ...

Bhad Bhabie revealed that she was given 'bad news' as she offered a heartbreaking health update amid her blood cancer battle.

Novo Nordisk is repriced as if its fundamentals have sharply deteriorated, despite strong underlying demand. Learn why NVO stock is rated a buy.

The drive will cover all 1.15 crore girls who turn 14 each year and will run as a special programme, separate from India’s Universal Immunisation Programme (UIP).

Discusses Phase III Results and Advances in Treating Acute Agitation in Alzheimer's Dementia February 27, 2026 2:00 ...

Mazda has such an awareness. The spec sheet for its new 323GTX reads like show­car material: twin camshafts, four valves per ...

It’s definitely been one long, strange trip.” Rob Zombie is reflecting, perhaps understatedly, on the prolific, unpredictable ...